Zhaoke Ophthalmology Limited (6622.HK)
HKD 1.32
(0.0%)
HKD 1.32
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -323.66 Million | -331.05 Million | -245.14 Million | -103.42 Million | -55.21 Million | 22.08 Million |
| Net Income | -384.48 Million | -407.31 Million | -2.12 Billion | -726.98 Million | -122.07 Million | -36.88 Million |
| Depreciation & Amortization | 48.7 Million | 35.07 Million | 25.83 Million | 19.85 Million | 16.56 Million | 9.46 Million |
| Deferred income taxes | - | - | -14.37 Million | 2.9 Million | - | - |
| Stock-based compensation | 22.02 Million | 46.68 Million | 109.85 Million | 14.99 Million | - | - |
| Change in working capital | 59.35 Million | 646 Thousand | 2.9 Million | -19 Million | 29.21 Million | 44.24 Million |
| Other non-cash items | -69.61 Million | -6.13 Million | 1.76 Billion | 604.8 Million | 21.08 Million | 5.25 Million |
| Investing Cash Flow | -75.76 Million | -324.56 Million | 683.52 Million | -955.48 Million | -104.99 Million | -14.65 Million |
| Investments in PPE | -95.26 Million | -238.55 Million | -94.49 Million | -175.95 Million | -25.34 Million | -18.92 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | -770.37 Million | -82.54 Million | - |
| Sales/Maturities of investments | 9.78 Million | - | 787.94 Million | - | - | - |
| Other Investing Activities | -88.17 Million | -86.01 Million | -9.92 Million | -9.15 Million | 2.89 Million | 4.26 Million |
| Financing Cash Flow | 99.29 Million | 76.23 Million | 1.65 Billion | 973.68 Million | 302.88 Million | -2.04 Million |
| Debt repayment | -112.07 Million | -9.6 Million | -400 Thousand | -3.4 Million | -2.98 Million | -717 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.85 Million | 1.25 Million | 1.74 Billion | - | 10.57 Million | - |
| Other Financing Activities | 108.05 Million | 84.58 Million | -84.41 Million | 977.08 Million | 295.29 Million | -1.32 Million |
| Accounts receivables | 14.76 Million | -27.66 Million | -28.82 Million | -3.43 Million | -5.41 Million | 5.91 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -6.14 Million | - | - | - | - | - |
| Other working capital | -4.42 Million | 28.3 Million | 31.73 Million | -15.57 Million | 34.62 Million | 38.33 Million |
| Cash at beginning of period | 1.71 Billion | 2.12 Billion | 65.09 Million | 154.76 Million | 7.21 Million | 1.83 Million |
| Cash at end of period | 1.46 Billion | 1.71 Billion | 2.12 Billion | 65.09 Million | 154.76 Million | 7.21 Million |
| Capital Expenditure | -95.26 Million | -238.55 Million | -94.49 Million | -175.95 Million | -25.34 Million | -18.92 Million |
| Effect of forex changes on cash | 45.41 Million | 167.31 Million | -33.56 Million | -4.45 Million | 4.86 Million | 3000.00 |
| Net cash flow / Change in cash | -254.72 Million | -412.07 Million | 2.06 Billion | -89.67 Million | 147.55 Million | 5.38 Million |
| Free Cash Flow | -418.93 Million | -569.6 Million | -339.63 Million | -279.38 Million | -80.55 Million | 3.15 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -37.9 Million | -37.9 Million | -384.48 Million | -75.63 Million | -75.63 Million | -116.88 Million |
| Depreciation & Amortization | 13.24 Million | 13.24 Million | 48.7 Million | 11.75 Million | 8.45 Million | 12.59 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 491 Thousand | 491 Thousand | 22.02 Million | 3.21 Million | 3.21 Million | 7.8 Million |
| Change in working capital | - | - | 59.35 Million | 5.16 Million | 5.16 Million | - |
| Other non-cash items | -54.04 Million | -54.04 Million | -69.61 Million | -20.61 Million | -17.3 Million | 10.77 Million |
| Investing Cash Flow | -39.71 Million | -39.71 Million | -75.76 Million | -42.16 Million | -42.16 Million | 4.27 Million |
| Investments in PPE | -3.45 Million | -3.45 Million | -95.26 Million | -2.35 Million | -2.35 Million | -15.88 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | 9.78 Million | - | - | 10.07 Million |
| Other Investing Activities | -36.26 Million | -36.26 Million | -88.17 Million | -39.8 Million | -39.8 Million | 20.15 Million |
| Financing Cash Flow | 4.6 Million | 4.6 Million | 99.29 Million | 21.5 Million | 21.5 Million | 28.14 Million |
| Debt repayment | - | - | -112.07 Million | - | - | -73.49 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 1.85 Million | - | - | - |
| Other Financing Activities | 4.6 Million | 4.6 Million | 108.05 Million | 21.5 Million | 21.5 Million | 28.14 Million |
| Accounts receivables | - | - | 14.76 Million | 7.38 Million | 7.38 Million | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | -6.14 Million | - | - | - |
| Other working capital | - | - | -4.42 Million | -2.21 Million | -2.21 Million | - |
| Cash at beginning of period | - | - | 1.71 Billion | - | - | 2.12 Billion |
| Cash at end of period | -97.34 Million | -97.34 Million | 1.46 Billion | -106.55 Million | -106.55 Million | 2.02 Billion |
| Capital Expenditure | -3.45 Million | -3.45 Million | -95.26 Million | -2.35 Million | -2.35 Million | -15.88 Million |
| Effect of forex changes on cash | 15.97 Million | 15.97 Million | 45.41 Million | -9.78 Million | -9.78 Million | 32.49 Million |
| Net cash flow / Change in cash | -97.34 Million | -97.34 Million | -254.72 Million | -106.55 Million | -106.55 Million | -93.73 Million |
| Free Cash Flow | -81.66 Million | -81.66 Million | -418.93 Million | -78.46 Million | -78.46 Million | -101.6 Million |
2455
HSCL
SIMPLXREA
HAR
PAT
GROC